1. Home
  2. HUMAW vs TALKW Comparison

HUMAW vs TALKW Comparison

Compare HUMAW & TALKW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Humacyte Inc. Warrant

HUMAW

Humacyte Inc. Warrant

HOLD

Current Price

$0.09

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

Logo Talkspace Inc. Warrant

TALKW

Talkspace Inc. Warrant

N/A

Current Price

$0.00

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HUMAW
TALKW
Founded
2004
2012
Country
United States
United States
Employees
220
521
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HUMAW
TALKW
Price
$0.09
$0.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
11.5K
177.2K
Earning Date
03-21-2025
02-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$181,291,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
31.50
52 Week Low
$0.08
$0.00
52 Week High
$0.60
$0.15

Technical Indicators

Market Signals
Indicator
HUMAW
TALKW
Relative Strength Index (RSI) 42.58 37.28
Support Level $0.09 N/A
Resistance Level $0.15 $0.01
Average True Range (ATR) 0.01 0.00
MACD -0.00 0.00
Stochastic Oscillator 9.65 13.64

Price Performance

Historical Comparison
HUMAW
TALKW

About HUMAW Humacyte Inc. Warrant

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

About TALKW Talkspace Inc. Warrant

Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.

Share on Social Networks: